Skip to content

Clinical trials

Withdrawn Primary Myelofibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Status: Withdrawn Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20151
20161
20181
20191
20201
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center2
Ascentage Pharma Group Inc.1
Case Comprehensive Cancer Center1
Fred Hutchinson Cancer Center1
Lynk Pharmaceuticals Co., Ltd1
M.D. Anderson Cancer Center1
Mayo Clinic1
Northwestern University1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis10
Myeloproliferative Disorders5
Polycythemia Vera5
Leukemia, Myeloid, Acute4
Leukemia, Myeloid, Chronic-Phase4
Lymphoma, Non-Hodgkin4
Hodgkin Disease3
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myeloid, Accelerated Phase3
Leukemia, Myelomonocytic, Chronic3

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.